Loading...

PE/Cyanine7 anti-mouse/human CD44 Antibody

Pricing & Availability
Clone
IM7 (See other available formats)
Regulatory Status
RUO
Other Names
Hermes, Pgp-1, H-CAM, HUTCH-1, ECMR III, gp85, Ly-24
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
IM7_PECy7_011108
C57BL/6 mouse splenocytes stained with IM7 PE/Cyanine7
  • IM7_PECy7_011108
    C57BL/6 mouse splenocytes stained with IM7 PE/Cyanine7
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103029 25 µg 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103030 100 µg 172€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD44 is a 80-95 kD glycoprotein also known as Hermes, Pgp1, H-CAM, or HUTCH. It is expressed on all leukocytes, endothelial cells, hepatocytes, and mesenchymal cells. As B and T cells become activated or progress to the memory stage, CD44 expression increases from low or mid levels to high levels. Thus, CD44 has been reported to be a valuable marker for memory cell subsets. High CD44 expression on Treg cells has been associated with potent suppressive function via high production of IL-10. CD44 is an adhesion molecule involved in leukocyte attachment to and rolling on endothelial cells, homing to peripheral lymphoid organs and to the sites of inflammation, and leukocyte aggregation.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human
Reported Reactivity
Chimpanzee, Baboon, Cynomolgus, Rhesus, Squirrel Monkey, Horse, Cow, Pig, Dog, Cat
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Dexamethasone-induced myeloid leukemia M1 cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone IM7 has been reported to recognize an epitope common to alloantigens and all isoforms of CD4417,18 that is located between amino acids 145 and 18620. This clone has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F). Additional reported applications (for the relevant formats) include: immunohistochemistry of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections6,7, complement-mediated cytotoxicity1, immunoprecipitation1,3, in vivo inhibition of DTH4,5, and spatial biology (IBEX)23,24. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103046, 103065 - 103069).

Cross-reactivity to ferret has been reported by a collaborator, but not verified in house.

Application References

(PubMed link indicates BioLegend citation)
  1. Trowbridge IS, et al. 1982. Immunogenetics 15:299. (ICFC, IP, CMCD)
  2. Katoh S, et al. 1994. J. Immunol. 153:3440. (ELISA)
  3. Budd RC, et al. 1987. J. Immunol. 138:3120. (IP)
  4. Camp RL, et al. 1993. J. Exp. Med. 178:497. (Block)
  5. Weiss JM, et al. 1997. J. Cell Biol. 137:1137. (Block)
  6. Frank NY, et al. 2005. Cancer Res. 65:4320. (IHC) PubMed
  7. Cuff CA, et al. 2001. J. Clin. Invest. 108:1031. (IHC)
  8. Lee JW, et al. 2006. Nature Immunol. 8:181.
  9. Zhang N, et al. 2005. J. Immunol. 174:6967. PubMed
  10. Huabiao C, et al. 2005. J. Immunol. 175:591. PubMed
  11. Gui J, et al. 2007. Int. Immunol. 19:1201. PubMed
  12. Wang XY, et al. 2008. Blood 111:2436. PubMed
  13. Kenna TJ, et al. 2008. Blood 111:2091. PubMed
  14. Yamazaki J, et al. 2009. Blood PubMed
  15. Kmieciak M, et al. 2009. J. Transl. Med. 7:89. (FC) PubMed
  16. Chen YW, et al. 2010. Mol. Cancer Ther. 9:2879. PubMed
  17. Zheng Z, et al. 1995. J. Cell. Biol. 130:485.
  18. Wiranowska M, et al. 2010. Int. J. Cancer 127:532.
  19. Hirokawa Y, et al. 2014. Am J Physiol Gastrointerest Liver Physiol. 306:547. PubMed
  20. Sandmaier BM, et al. 1998. Blood 91:3494.
  21. Yang Y, et al. 2015. Hypertension. 65:1047. PubMed
  22. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
  2. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  3. Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed
  4. Zhang D, et al. 2022. Cell Stem Cell. 29:232. PubMed
  5. Koenig A, et al. 2022. Front Immunol. 12:791100. PubMed
  6. Parga-Vidal L, et al. 2022. Eur J Immunol. 52:1095. PubMed
  7. Liedmann S, et al. 2022. Mol Cell. 82:2401. PubMed
  8. Brown MS, et al. 2022. Sci Adv. 8:eabj8002. PubMed
  9. Koizumi M, et al. 2022. J Biol Chem. 298:102506. PubMed
  10. Ogishi M, et al. 2023. J Exp Med. 220: . PubMed
  11. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  12. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  13. Lombard-Vadnais F, et al. 2023. iScience. 26:105852. PubMed
  14. Nettersheim FS, et al. 2023. Front Cardiovasc Med. 9:1076808. PubMed
  15. Scherer S, et al. 2023. Nat Immunol. 24:501. PubMed
  16. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  17. Hailemichael Y, et al. 2022. Cancer Cell. 40:509. PubMed
  18. Wang Y, et al. 2023. J Nanobiotechnology. 21:109. PubMed
  19. del Rio ML, et al. 2023. Front Immunol. 14:1113858. PubMed
  20. Wang X, et al. 2023. Nat Commun. 14:3440. PubMed
  21. Liu Y, et al. 2023. Nat Commun. 14:3745. PubMed
  22. Chen H, et al. 2005. J Immunol. 175:591. PubMed
  23. Shimizu K, et al. 2020. Molecular Cell. 77(5):937-950.e6.. PubMed
  24. Qian Y, et al. 2021. Cell Reports. 36(8):109602. PubMed
  25. Marco Barros R, et al. 2016. Cell. 167: 203-218. PubMed
  26. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  27. Gerber AN, et al. 2021. Cell Rep. 37:109816. PubMed
  28. Hu J, et al. 2022. J Immunother Cancer. 10:. PubMed
  29. Koh CH, et al. 2020. Cancer Immunol Res. 8:698. PubMed
  30. Wang D, et al. 2018. Immunity. 48:659. PubMed
  31. Zhang P et al. 2019. Cell Rep. 27(11):3117-3123 . PubMed
  32. Aldon Y, et al. 2020. J Immunol. 204:903. PubMed
  33. Baranek T, et al. 2020. Cell Reports. 32(10):108116. PubMed
  34. Almeida D, et al. 2010. J Immunol. 185:1927. PubMed
  35. Wabitsch S, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1166. PubMed
  36. He X, et al. 2021. Cell Rep. 36:109674. PubMed
  37. Pal D et al. 2017. eLife. 6 pii: e21615. PubMed
  38. Bhattacharjee S, et al. 2019. Cell Rep. 28:231. PubMed
  39. Gotoh K et al. 2018. Cell reports. 25(7):1800-1815 . PubMed
  40. del Rio ML, et al. 2021. Transl Res. Online ahead of print.. PubMed
  41. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  42. Feizi N, et al. 2021. Cell Death Dis. 12:1026. PubMed
  43. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  44. Gondek D, et al. 2012. J Immunol. 189:2441. PubMed
  45. LaMothe RA et al. 2018. Front Immunol. 0.570138889 . PubMed
  46. Zhan CS, et al. 2020. FASEB J. 14006:34. PubMed
  47. Li Y, et al. 2020. Nat Commun. 11:2781. PubMed
  48. Han Y, et al. 2019. Am J Cancer Res. 9:800. PubMed
  49. Ueda R, et al. 2009. Clin Cancer Res. 5.215972222. PubMed
  50. Bolinger B, et al. 2013. J Immunol. 190:4162. PubMed
  51. Kersh A, et al. 2014. J Immunol. 193:4429. PubMed
  52. Yu Y, et al. 2022. Nat Commun. 13:6357. PubMed
  53. Luo Y et al. 2019. Cell reports. 26(7):1869-1879 . PubMed
  54. Nanou A, et al. 2020. Haematologica. . PubMed
  55. Ruf B, et al. 2021. Cancer Immunol Res. 9:1024. PubMed
  56. Stewart JM, et al. 2020. ACS Biomater Sci Eng. 6:5941. PubMed
  57. Sinclair LV et al. 2019. Elife. 8 pii: e44210. PubMed
  58. Ise W, et al. 2018. Immunity. 48:702. PubMed
  59. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  60. Ruer-Laventie J, et al. 2020. Bio Protoc. e3531:10. PubMed
  61. Oladiran O, et al. 2021. J Neuroinflammation. 77:18. PubMed
  62. Akazawa S, et al. 2021. Diabetologia. 64:878. PubMed
  63. Pitsch J, et al. 2021. Ann Neurol. 89:666. PubMed
  64. Wang D, et al. 2020. J Cell Mol Med. 24:4212. PubMed
  65. Sun L, et al. 2021. Cell Reports. 35(9):109188. PubMed
  66. Vishnoi M, et al. 2015. Sci Rep. 5: 17533. PubMed
  67. Burrack K, et al. 2015. J Immunol. 194:678. PubMed
  68. Chen X, et al. 2021. Cell Rep. 37:109991. PubMed
  69. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  70. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  71. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  72. Alvim RG, et al. 2021. Molecules. 26:. PubMed
  73. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  74. Anger-Góra N, et al. 2021. Oncol Lett. 22:582. PubMed
  75. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  76. Chulkina M, et al. 2017. Eur J Pharmacol. 10.1016/j.ejphar.2017.06.033. PubMed
  77. Jandke A, et al. 2020. Nat Commun. 3.075694444. PubMed
  78. Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
  79. Gong N, et al. 2020. Nat Nanotechnol. 1.35625. PubMed
  80. Limbach K, et al. 2017. Malar J. 10.1186/s12936-017-1911-z. PubMed
  81. Yomtoubian S, et al. 2020. Cell Reports. 30(3):755-770.e6.. PubMed
  82. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  83. Jeljeli M, et al. 2021. Front Immunol. 12:670776. PubMed
  84. Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed
  85. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  86. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  87. Amezcua Vesely MC, et al. 2020. Cell. 178(5):1176-1188.e15.. PubMed
  88. Salazar V, et al. 2019. Cell Rep. 26:1585. PubMed
  89. Hendrikx S et al. 2019. Cell reports. 26(5):1227-1241 . PubMed
  90. Field CS, et al. 2020. Cell Metab. 31:422. PubMed
  91. Jeon Y, et al. 2015. PLoS One. 10: e0139845. PubMed
  92. Xu W, et al. 2019. Immunity. 51(5):826-839.e5. PubMed
  93. Castillo–Azofeifa D, et al. 2019. EMBO J. 38:e99984. PubMed
  94. Belogortseva N, et al. 2017. PLoS One.. 10.1371/journal.pone.0182825. PubMed
  95. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  96. Kitagawa K, et al. 2014. Mol Cell Biol. 34:2732. PubMed
  97. Skirecki T, et al. 2020. JCI Insight. 5:. PubMed
  98. Wang X, et al. 2022. Elife. 11:. PubMed
  99. Malenica I, et al. 2021. Nat Commun. 12:5209. PubMed
  100. Miao Y et al. 2019. Cell. 177(5):1172-1186 . PubMed
  101. Pattabiraman D, et al. 2016. Science. 351: aad3680. PubMed
  102. Hsu HP, et al. 2021. J Biol Chem. 296:100419. PubMed
  103. Dourcy M, et al. 2020. Mucosal Immunol. 13:799. PubMed
  104. Rodrigues KA, et al. 2021. Sci Adv. 7:eabj6538. PubMed
  105. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  106. Aihara E, et al. 2015. Sci Rep. 5:17185. PubMed
  107. Pan Y, et al. 2021. NPJ Vaccines. 6:1. PubMed
RRID
AB_830786 (BioLegend Cat. No. 103029)
AB_830786 (BioLegend Cat. No. 103030)

Antigen Details

Structure
Variable splicing of CD44 gene generates many CD44 isoforms, 80-95 kD
Distribution

All leukocytes, epithelial cells, endothelial cells, hepatocytes, mesenchymal cells

Function
Leukocyte attachment and rolling on endothelial cells, stromal cells and ECM
Ligand/Receptor
Hyaluronan, MIP-1β, fibronectin, collagen
Cell Type
B cells, Endothelial cells, Epithelial cells, Leukocytes, Mesenchymal cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Immunology, Stem Cells
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Haynes BF, et al. 1991. Cancer Cells 3:347.
3. Goldstein LA, et al. 1989. Cell 56:1063.
4. Mikecz K, et al. 1995. Nat. Med. 1:558.
5. Hegde V, et al. 2008. J. Leukocyte Biol. 84:134.
6. Liu T, et al. 2009. Biol. Direct 4:40.

Gene ID
12505 View all products for this Gene ID 960 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD44
Specificity Alt (DOES NOT SHOW ON TDS):
CD44
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD44 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD44 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD44 IM7 FC
Biotin anti-mouse/human CD44 IM7 FC,ICC,IHC-P
FITC anti-mouse/human CD44 IM7 FC,ICC,IHC-P
PE/Cyanine5 anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 IM7 FC,IHC-F,CyTOF®,ELISA,ICC,IHC-P,IP,CMCD,Stim
Brilliant Violet 605™ anti-mouse/human CD44 IM7 FC
PE anti-mouse/human CD44 IM7 FC
Alexa Fluor® 488 anti-mouse/human CD44 IM7 FC,ICC,IHC-P,SB
Alexa Fluor® 647 anti-mouse/human CD44 IM7 FC,ICC,SB
Pacific Blue™ anti-mouse/human CD44 IM7 FC
Alexa Fluor® 700 anti-mouse/human CD44 IM7 FC,SB
PE/Cyanine7 anti-mouse/human CD44 IM7 FC
APC/Cyanine7 anti-mouse/human CD44 IM7 FC
PerCP/Cyanine5.5 anti-mouse/human CD44 IM7 FC
PerCP anti-mouse/human CD44 IM7 FC
Brilliant Violet 421™ anti-mouse/human CD44 IM7 FC,ICC,IHC-P
Brilliant Violet 570™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 785™ anti-mouse/human CD44 IM7 FC
Brilliant Violet 510™ anti-mouse/human CD44 IM7 FC
Ultra-LEAF™ Purified anti-mouse/human CD44 IM7 FC,CyTOF®,ELISA,IHC,IP,CMCD,Stim
Brilliant Violet 650™ anti-mouse/human CD44 IM7 FC
Purified anti-mouse/human CD44 (Maxpar® Ready) IM7 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD44 IM7 ICC,FC,IHC-P,SB
PE/Dazzle™ 594 anti-mouse/human CD44 IM7 FC
Brilliant Violet 711™ anti-mouse/human CD44 IM7 FC
APC/Fire™ 750 anti-mouse/human CD44 IM7 FC
TotalSeq™-A0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-C0073 anti-mouse/human CD44 IM7 PG
TotalSeq™-B0073 anti-mouse/human CD44 IM7 PG
Spark YG™ 570 anti-mouse/human CD44 IM7 FC,IHC-P
Spark YG™ 593 anti-mouse/human CD44 IM7 FC
TotalSeq™-D0073 anti-mouse/human CD44 IM7 PG
Brilliant Violet 750™ anti-mouse/human CD44 IM7 FC
PerCP/Fire™ 806 anti-mouse/human CD44 IM7 FC
Spark Red™ 718 anti-mouse/human CD44 IM7 FC
PE/Fire™ 810 anti-mouse/human CD44 IM7 FC
Spark Blue™ 550 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Spark Red™ 718 anti-mouse/human CD44 (Flexi-Fluor™) IM7 FC
Go To Top Version: 2    Revision Date: 09.11.2014

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account